查看购物车
  • Traditional Chinese
  • English
小分子药物发现市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按治疗领域、製程/阶段和地理位置
市场调查报告书
商品编码
1591417

小分子药物发现市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按治疗领域、製程/阶段和地理位置

Small Molecule Drug Discovery Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapeutic Area, Process/Phase, and Geography
出版日期: | 出版商: The Insight Partners | 英文 140 Pages | 订单完成后即时交付

价格

小分子药物发现市场预计将从 2023 年的 509.3 亿美元成长到 2031 年的 1,067.7 亿美元；预计 2023-2031 年复合年增长率为 9.7%。蓬勃发展的製药业、研发活动的激增以及外包倾向的不断增强，正在促进小分子药物发现市场的成长。然而，高昂的药物开发成本阻碍了市场成长。此外，人工智慧在药物发现中的日益采用预计将在未来几年带来新的小分子药物发现市场趋势。

2023年，北美占据全球小分子药物发现市场的主要份额。製药和生物技术公司在发现新药方面不断增加的研究和开发、对药品的投资不断增加以及癌症的盛行率预计将加速北美小分子药物发现市场的成长。美国是北美最发达的国家之一。心血管疾病和癌症等慢性疾病的盛行率不断上升，主要推动了该国市场的成长。根据美国癌症协会的数据，到 2024 年，美国预计将有约 200 万人患有新癌症病例，预计将有约 611,000 例死亡病例。由于这种情况，美国卫生系统在新型药物分子的研发方面投入了大量资金。此外，强大的药物管道以及小分子药物治疗领域的批准预计将推动该区域市场的发展。除了批准药物数量的增加之外，对先进疗法的认识不断提高也可能是预测期内小分子药物发现市场成长的原因。

加拿大小分子药物发现市场的成长归因于政府措施的增加和癌症盛行率的增加，以及主要参与者的策略性倡议。由于提供创新的治疗选择，加拿大人能够应对各种医疗状况。加拿大医疗保健中小分子药物的日益普及可能会在未来几年继续推动市场成长。

根据加拿大政府的数据，就销售额而言，该国在全球最大的医药市场中排名第九。创新製药公司、药品製造商、合约研究组织（CRO）和中小型生物製药公司是如此巨大销售价值的主要推动者。根据加拿大统计局 2020 年的数据，有 6,280 家公司在加拿大营运。医药业占整个医疗保健产业的41%，研发业占31%。因此，快速成长的製药和生物製药产业在加拿大产生了对小分子药物发现的巨大需求。

增加小分子产品管线为未来提供市场机会

製药业不断发展，始终需要新的、创新的治疗方法来治疗各种慢性适应症。过去五年，小分子药物的批准数量有所增加，因为它们对多种适应症有效。基于小分子候选药物的产品线正在不断增长，用于广泛的治疗应用，包括肿瘤学、高血压、糖尿病和发炎性疾病。许多大大小小的製药公司都在从事多种小分子药物的开发。

针对各种适应症的小分子药物不断增加，反过来又促进了整个产业的药物发现活动。

化合物名称 化合物类型 公司名称 临床阶段 适应症

PF-06821497 小分子辉瑞公司 1 期癌症

PF-06873600 小分子辉瑞公司第 1 期乳癌转移

PF-06939999 小分子辉瑞公司 1 期实体瘤

PF-06952229 小分子辉瑞公司 1 期癌症

PF-06826647 小分子辉瑞公司 1 期溃疡性结肠炎

PF-07038124 小分子辉瑞公司 1 期异位性皮肤炎

PF-06842874 小分子辉瑞公司 1 期肺动脉高压

PF-06865571 小分子辉瑞公司 1 期非酒精性脂肪性肝炎 (NASH) 伴随肝纤维化

PF-06882961 小分子辉瑞公司第 1 期糖尿病 2 型，肥胖

PF-07081532 小分子辉瑞公司第 1 期糖尿病 2 型，肥胖

R835 小分子 Rigel Pharmaceuticals, Inc. 第 1 期炎症

疾病

R552 小分子 Rigel Pharmaceuticals, Inc. 第 1 期炎症

疾病

SY-1425 小分子 Syros Pharmaceuticals, Inc. 2 期 AML

资料来源：公司新闻和 Insight 合作伙伴分析

小分子药物发现市场：竞争格局与关键发展

Bristol-Myers Squibb Co、Merck KGaA、GSK Plc、Boehringer Ingelheim International GmbH、Thermo Fisher Scientific Inc、ICON Plc、Danaher Corp、Charles River Laboratories International Inc、Oncodesign Services 和 Revvity Inc 是小分子领域的主要公司之一药物发现市场。

美国食品药物管理局、疾病管制与预防中心 (CDC) 以及药物开发研究中心是准备小分子药物发现市场报告时参考的主要和次要来源。

目录

第 1 章：简介

第 2 章：执行摘要

  • 关键见解。

第 3 章：研究方法

  • 二次研究。
  • 初步研究。
    • 假设表述：
    • 宏观经济因素分析：
    • 显影基数：
    • 数据三角测量：
    • 国家级资料：

第 4 章：小分子药物发现市场格局

  • 概述。
  • PEST 分析。

第 5 章：小分子药物发现市场 - 主要市场动态

  • 小分子药物发现市场 - 主要市场动态。
  • 市场驱动因素。
    • 医药产业蓬勃发展，研发活动激增。
    • 越来越倾向外包。
  • 市场限制。
    • 药物开发成本高
  • 市场机会。
    • 增加基于小分子的管道。
  • 未来趋势。
    • 人工智慧在药物发现的应用越来越广泛。
  • 驱动因素和限制的影响：

第 6 章：小分子药物发现市场 - 全球市场分析

  • 小分子药物发现市场收入，2021-2031。
  • 小分子药物发现市场预测分析。

第 7 章：小分子药物发现市场分析 - 按治疗领域

  • 肿瘤学。
  • 中枢神经系统..
  • 心血管
  • 呼吸系统。
  • 骨科。
  • 免疫学。
  • 罕见疾病。
  • 其他治疗领域。

第 8 章：小分子药物发现市场分析 - 按过程或阶段

  • 目标发现。
  • 目标验证。
  • 潜在客户的产生与完善
  • 临床前开发

第 9 章：小分子药物发现市场 - 地理分析

  • 北美。
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区。
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳洲
      • 亚太地区其他地区
  • 中东和非洲。
    • 中东和非洲
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 南非
      • 中东和非洲其他地区
  • 南美洲和中美洲。
    • 南美洲和中美洲
      • 巴西
      • 阿根廷
      • 南美洲和中美洲其他地区

第 10 章：产业格局

  • 概述。

第 11 章：公司简介

  • Bristol-Myers Squibb Co.
  • Merck KGaA.
  • GSK Plc.
  • Thermo Fisher Scientific Inc.
  • ICON Plc.
  • Danaher Corp.
  • Charles River Laboratories International Inc.
  • Oncodesign Services.
  • Revvity Inc.
  • Boehringer Ingelheim International GmbH.

第 12 章：附录

Product Code: TIPRE00004774

The Small Molecule Drug Discovery market is anticipated to grow from US$ 50.93 billion in 2023 and is projected to reach US$ 106.77 billion by 2031; it is expected to register a CAGR of 9.7% during 2023-2031. Flourishing pharmaceutical industry with surge in R&D activities and growing inclination toward outsourcing are contributing to the small molecule drug discovery market growth. However, high drug development costs hamper market growth. Further, the growing adoption of artificial intelligence in drug discovery is expected to bring new small molecule drug discovery market trends in the coming years.

North America accounted for a major share of the global small molecule drug discovery market in 2023. The North America small molecule drug discovery market is segmented into the US, Canada, and Mexico. Increasing research and development by pharmaceutical and biotechnology companies in discovering novel drugs, growing investments in pharmaceuticals, and prevalence of cancer are among the factors that are projected to accelerate the growth of the North America small molecule drug discovery market. The US is one of the most developed countries in North America. The increasing prevalence of chronic diseases such as cardiovascular diseases and cancer primarily drives the market growth in the country. As per the American Cancer Society, in 2024, ~2 million people are projected to suffer from new cancer cases, and ~611,000 death cases are expected to be registered in the US. Owing to this scenario, the US health system witnesses massive investments in research and developments for novel drug molecules. Further, a strong drug pipeline, along with therapeutic area approvals for small molecule drugs, is expected to drive the regional market. Apart from the rising number of approved drugs, increasing awareness of advanced therapeutics is likely to be responsible for the growth of the small molecule drug discovery market during the forecast period.

The growth of the Canada small molecule drug discovery market is attributed to increasing government initiatives and growing cancer prevalence, as well as strategic initiatives by the major players. Canadians are able to deal with a variety of medical conditions due to the availability of innovative treatment options. The rising adoption of small molecule medicines in Canadian healthcare is likely to continue to boost the market growth over the coming years.

As per the Government of Canada, the country ranks ninth among the largest pharmaceutical markets in the world in terms of sales value. Innovative pharmaceutical companies, drug manufacturers, contract research organizations (CROs), and small- and medium-sized biopharmaceutical companies are among the major enablers of such a huge sales value. According to Statistics Canada 2020, 6,280 companies were operating in Canada. The pharmaceutical sector accounts for 41%, and the research and development sector accounts for 31% of its overall healthcare sector. Thus, the rapidly growing pharmaceutical and biopharmaceutical industries generate a huge demand for small molecule drug discovery in Canada.

Increasing Small Molecule-Based Pipeline to Provide Market Opportunities in Future

The pharmaceutical industry is continually evolving and there is always a need for new, innovative therapeutic approaches in the treatment of various chronic indications. Small molecule-based drug approvals have been increased in the past five years owing to their effectiveness against a wide range of indications. Small molecule drug candidate-based pipelines are growing for a wide range of therapeutic applications, including oncology, hypertension, diabetes, and inflammatory disorders. Many big and small pharmaceutical companies are engaged in the development of several small-molecule drugs.

The growing pipeline of small molecule-based drugs for various indications is, in turn, boosting drug discovery activities across the industry.

Compound Name Compound Type Company Name Clinical Phase Indication

PF-06821497 Small Molecule Pfizer Inc. Phase 1 Cancer

PF-06873600 Small Molecule Pfizer Inc. Phase 1 Breast Cancer Metastatic

PF-06939999 Small Molecule Pfizer Inc. Phase 1 Solid Tumors

PF-06952229 Small Molecule Pfizer Inc. Phase 1 Cancer

PF-06826647 Small Molecule Pfizer Inc. Phase 1 Ulcerative Colitis

PF-07038124 Small Molecule Pfizer Inc. Phase 1 Atopic Dermatitis

PF-06842874 Small Molecule Pfizer Inc. Phase 1 Pulmonary Arterial Hypertension

PF-06865571 Small Molecule Pfizer Inc. Phase 1 Non-alcoholic Steatohepatitis (NASH) with Liver Fibrosis

PF-06882961 Small Molecule Pfizer Inc. Phase 1 Diabetes Mellitus-Type 2, Obesity

PF-07081532 Small Molecule Pfizer Inc. Phase 1 Diabetes Mellitus-Type 2, Obesity

R835 Small Molecule Rigel Pharmaceuticals, Inc. Phase 1 Inflammatory

Disorders

R552 Small Molecule Rigel Pharmaceuticals, Inc. Phase 1 Inflammatory

Disorders

SY-1425 Small Molecule Syros Pharmaceuticals, Inc. Phase 2 AML

Source: Company News and The Insight Partner Analysis

Small Molecule Drug Discovery Market: Competitive Landscape and Key Developments

Bristol-Myers Squibb Co, Merck KGaA, GSK Plc, Boehringer Ingelheim International GmbH, Thermo Fisher Scientific Inc, ICON Plc, Danaher Corp, Charles River Laboratories International Inc, Oncodesign Services, and Revvity Inc are among the key companies operating in the small molecule drug discovery market.

The US Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Centre for the Study of Drug Development are among the primary and secondary sources referred to while preparing the small molecule drug discovery market report.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance.
  • 1.2 Market Segmentation.

2. Executive Summary

  • 2.1 Key Insights.

3. Research Methodology

  • 3.1 Secondary Research.
  • 3.2 Primary Research.
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.1 Developing base number:
    • 3.2.2 Data Triangulation:
    • 3.2.3 Country level data:

4. Small Molecule Drug Discovery Market Landscape

  • 4.1 Overview.
  • 4.2 PEST Analysis.

5. Small Molecule Drug Discovery Market - Key Market Dynamics

  • 5.1 Small Molecule Drug Discovery Market - Key Market Dynamics.
  • 5.2 Market Drivers.
    • 5.2.1 Flourishing Pharmaceutical Industry with Surge in R&D Activities.
    • 5.2.2 Growing Inclination Toward Outsourcing.
  • 5.3 Market Restraints.
    • 5.3.1 High Drug Development Cost
  • 5.4 Market Opportunities.
    • 5.4.1 Increasing Small Molecule-Based Pipeline.
  • 5.5 Future Trends.
    • 5.5.1 Growing Adoption of Artificial Intelligence in Drug Discovery.
  • 5.6 Impact of Drivers and Restraints:

6. Small Molecule Drug Discovery Market - Global Market Analysis

  • 6.1 Small Molecule Drug Discovery Market Revenue (US$ Million), 2021-2031.
  • 6.2 Small Molecule Drug Discovery Market Forecast Analysis.

7. Small Molecule Drug Discovery Market Analysis - by Therapeutic Area

  • 7.1 Oncology.
    • 7.1.1 Overview.
    • 7.1.2 Oncology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.2 Central Nervous System..
    • 7.2.1 Overview.
    • 7.2.2 Central Nervous System: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 Cardiovascular
    • 7.3.1 Overview.
    • 7.3.2 Cardiovascular: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Respiratory.
    • 7.4.1 Overview.
    • 7.4.2 Respiratory: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Orthopedics.
    • 7.5.1 Overview.
    • 7.5.2 Orthopedics: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Immunology.
    • 7.6.1 Overview.
    • 7.6.2 Immunology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Rare Diseases.
    • 7.7.1 Overview.
    • 7.7.2 Rare Diseases: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.8 Other Therapeutic Areas.
    • 7.8.1 Overview.
    • 7.8.2 Other Therapeutic Areas: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)

8. Small Molecule Drug Discovery Market Analysis - by Process or Phase

  • 8.1 Target Discovery.
    • 8.1.1 Overview.
    • 8.1.2 Target Discovery: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.2 Target Validation.
    • 8.2.1 Overview.
    • 8.2.2 Target Validation: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Lead Generation and Refinement
    • 8.3.1 Overview.
    • 8.3.2 Lead Generation and Refinement: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Preclinical Development
    • 8.4.1 Overview.
    • 8.4.2 Preclinical Development: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)

9. Small Molecule Drug Discovery Market - Geographical Analysis

  • 9.1 North America.
    • 9.1.1 North America Small Molecule Drug Discovery Market Overview.
    • 9.1.2 North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.1.3 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.1.4 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.1.5 North America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.1.5.1 United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.1.1 United States: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.1.2 United States: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.1.5.2 Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.2.1 Canada: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.2.2 Canada: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.1.5.3 Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.1.5.3.1 Mexico: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.1.5.3.2 Mexico: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.2 Europe
    • 9.2.1 Europe Small Molecule Drug Discovery Market Overview.
    • 9.2.2 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.2.3 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.2.4 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.2.5 Europe: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.2.5.1 Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.1.1 Germany: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.1.2 Germany: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.2 France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.2.1 France: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.2.2 France: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.3 United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.3.1 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.3.2 United Kingdom: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.4 Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.4.1 Italy: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.4.2 Italy: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.5 Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.5.1 Spain: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.5.2 Spain: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.2.5.6 Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.2.5.6.1 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.2.5.6.2 Rest of Europe: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.3 Asia Pacific.
    • 9.3.1 Asia Pacific Small Molecule Drug Discovery Market Overview.
    • 9.3.2 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.3.3 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.3.4 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.3.5 Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.3.5.1 Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.1.1 Japan: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.1.2 Japan: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.2 China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.2.1 China: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.2.2 China: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.3 India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.3.1 India: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.3.2 India: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.4 South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.4.1 South Korea: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.4.2 South Korea: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.5 Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.5.1 Australia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.5.2 Australia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.3.5.6 Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.3.5.6.1 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.3.5.6.2 Rest of APAC: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.4 Middle East & Africa.
    • 9.4.1 Middle East & Africa Small Molecule Drug Discovery Market Overview.
    • 9.4.2 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.4.3 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.4.4 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.4.5 Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.4.5.1 Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.1.1 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.1.2 Saudi Arabia: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.2 United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.2.1 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.2.2 United Arab Emirates: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.3 South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.3.1 South Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.3.2 South Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.4.5.4 Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.4.5.4.1 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.4.5.4.2 Rest of Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
  • 9.5 South & Central America.
    • 9.5.1 South & Central America Small Molecule Drug Discovery Market Overview.
    • 9.5.2 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
    • 9.5.3 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Therapeutic Area.
    • 9.5.4 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Process or Phase.
    • 9.5.5 South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast Analysis - by Country.
      • 9.5.5.1 Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.1.1 Brazil: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.1.2 Brazil: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.5.5.2 Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.2.1 Argentina: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.2.2 Argentina: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.
      • 9.5.5.3 Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
        • 9.5.5.3.1 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area.
        • 9.5.5.3.2 Rest of South & Central America: Small Molecule Drug Discovery Market Breakdown, by Process or Phase.

10. Industry Landscape

  • 10.1 Overview.

11. Company Profiles

  • 11.1 Bristol-Myers Squibb Co.
    • 11.1.1 Key Facts.
    • 11.1.2 Business Description.
    • 11.1.3 Products and Services.
    • 11.1.4 Financial Overview.
    • 11.1.5 SWOT Analysis.
    • 11.1.6 Key Developments.
  • 11.2 Merck KGaA.
    • 11.2.1 Key Facts.
    • 11.2.2 Business Description.
    • 11.2.3 Products and Services.
    • 11.2.4 Financial Overview.
    • 11.2.5 SWOT Analysis.
    • 11.2.6 Key Developments.
  • 11.3 GSK Plc.
    • 11.3.1 Key Facts.
    • 11.3.2 Business Description.
    • 11.3.3 Products and Services.
    • 11.3.4 Financial Overview.
    • 11.3.5 SWOT Analysis.
    • 11.3.6 Key Developments.
  • 11.4 Thermo Fisher Scientific Inc.
    • 11.4.1 Key Facts.
    • 11.4.2 Business Description.
    • 11.4.3 Products and Services.
    • 11.4.4 Financial Overview.
    • 11.4.5 SWOT Analysis.
    • 11.4.6 Key Developments.
  • 11.5 ICON Plc.
    • 11.5.1 Key Facts.
    • 11.5.2 Business Description.
    • 11.5.3 Products and Services.
    • 11.5.4 Financial Overview.
    • 11.5.5 SWOT Analysis.
    • 11.5.6 Key Developments.
  • 11.6 Danaher Corp.
    • 11.6.1 Key Facts.
    • 11.6.2 Business Description.
    • 11.6.3 Products and Services.
    • 11.6.4 Financial Overview.
    • 11.6.5 SWOT Analysis.
    • 11.6.6 Key Developments.
  • 11.7 Charles River Laboratories International Inc.
    • 11.7.1 Key Facts.
    • 11.7.2 Business Description.
    • 11.7.3 Products and Services.
    • 11.7.4 Financial Overview.
    • 11.7.5 SWOT Analysis.
    • 11.7.6 Key Developments.
  • 11.8 Oncodesign Services.
    • 11.8.1 Key Facts.
    • 11.8.2 Business Description.
    • 11.8.3 Products and Services.
    • 11.8.4 Financial Overview.
    • 11.8.5 SWOT Analysis.
    • 11.8.6 Key Developments.
  • 11.9 Revvity Inc.
    • 11.9.1 Key Facts.
    • 11.9.2 Business Description.
    • 11.9.3 Products and Services.
    • 11.9.4 Financial Overview.
    • 11.9.5 SWOT Analysis.
    • 11.9.6 Key Developments.
  • 11.10 Boehringer Ingelheim International GmbH.
    • 11.10.1 Key Facts.
    • 11.10.2 Business Description.
    • 11.10.3 Products and Services.
    • 11.10.4 Financial Overview.
    • 11.10.5 SWOT Analysis.
    • 11.10.6 Key Developments.

12. Appendix

  • 12.1 About The Insight Partners.
  • 12.2 Glossary of Terms.

List Of Tables

  • Table 1. Small Molecule Drug Discovery Market Segmentation.
  • Table 2. R&D Investments by Major Pharmaceutical Companies.
  • Table 3. Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Table 4. North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 5. North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 6. United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 7. United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 8. Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 9. Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 10. Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 11. Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 12. Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 13. Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 14. Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 15. Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 16. France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 17. France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 18. United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 19. United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 20. Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 21. Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 22. Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 23. Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 24. Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 25. Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 26. Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 27. Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 28. Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 29. Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 30. China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 31. China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 32. India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 33. India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 34. South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 35. South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 36. Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 37. Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 38. Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 39. Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 40. Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 41. Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 42. Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 43. Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 44. United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 45. United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 46. South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 47. South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 48. Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million) - by Therapeutic Area.
  • Table 49. Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 50. South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 51. South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 52. Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 53. Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 54. Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 55. Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Process or Phase.
  • Table 56. Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million) - by Therapeutic Area.
  • Table 57. Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million) - by Process or Phase.
  • Table 58. Recent Inorganic Growth Strategies in the Small Molecule Drug Discovery Market
  • Table 59. Glossary of Terms, Small Molecule Drug Discovery Market

List Of Figures

  • Figure 1. Small Molecule Drug Discovery Market Segmentation, by Geography.
  • Figure 2. PEST Analysis.
  • Figure 3. Impact Analysis of Drivers and Restraints.
  • Figure 4. Small Molecule Drug Discovery Market Revenue (US$ Million), 2021-2031.
  • Figure 5. Small Molecule Drug Discovery Market Share (%) - by Therapeutic Area (2023 and 2031)
  • Figure 6. Oncology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 7. Central Nervous System: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 8. Cardiovascular: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 9. Respiratory: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 10. Orthopedics: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 11. Immunology: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 12. Rare Diseases: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 13. Other Therapeutic Areas: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 14. Small Molecule Drug Discovery Market Share (%) - by Process or Phase (2023 and 2031)
  • Figure 15. Target Discovery: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 16. Target Validation: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 17. Lead Generation and Refinement: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 18. Preclinical Development: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 19. North America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 20. North America: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 21. United States: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 22. Canada: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 23. Mexico: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 24. Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 25. Europe: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 26. Germany: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 27. France: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 28. United Kingdom: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 29. Italy: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 30. Spain: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 31. Rest of Europe: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 32. Asia Pacific: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 33. Asia Pacific: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 34. Japan: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 35. China: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 36. India: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 37. South Korea: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 38. Australia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 39. Rest of APAC: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 40. Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 41. Middle East & Africa: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 42. Saudi Arabia: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 43. United Arab Emirates: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 44. South Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 45. Rest of Middle East & Africa: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)
  • Figure 46. South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 47. South & Central America: Small Molecule Drug Discovery Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 48. Brazil: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 49. Argentina: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031(US$ Million)
  • Figure 50. Rest of South & Central America: Small Molecule Drug Discovery Market - Revenue and Forecast to 2031 (US$ Million)